TMCnet News
Research and Markets: Tinnitus - Pipeline Review, H2 2013 Research ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/7r67r9/tinnitus) has announced the addition of the "Tinnitus - Pipeline Review, H2 2013" report to their offering. 'Tinnitus - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Tinnitus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tinnitus. Scope - A snapshot of the global therapeutic scenario for Tinnitus. - A review of the Tinnitus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Tinnitus pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Tinnitus Overview Therapeutics Development Pipeline Products for Tinnitus - Overview Pipeline Products for Tinnitus - Comparative Analysis Late Stage Products Clinical Stage Products Early Stage Products Unknown Stage Products Tinnitus - Products under Development by Companies Tinnitus - Products under Investigation by Universities/Institutes Tinnitus - Companies Involved in Therapeutics Development Tinnitus - Therapeutics Assessment Drug Profiles esketamine hydrochloride - Drug Profile Product Description Mechanism of Action R&D Progress neramexane mesylate - Drug Profile BGG-492 - Drug Profile JB-004/A - Drug Profile Drug For Tinnitus - Drug Profile oxcarbazepine - Drug Profile gacyclidine - Drug Profile AUT-00063 - Drug Profile memantine hydrochloride - Drug Profile AUT-3 - Drug Profile YH_Herb - Drug Profile acamprosate - Drug Profile Featured News & Press Releases Appendix List of Tables List of Figures Companies Mentioned Novartis AG Merz Pharma GmbH & Co. KgaA Yuhan Corporation Auris Medical AG Otonomy, Inc. Synphora AB Flexion Therapeutics, Inc. Autifony Therapeutics Limited For more information visit http://www.researchandmarkets.com/research/7r67r9/tinnitus About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
